Clinical Trial Details

Trial ID: L0835
Source ID: NCT03047668
Associated Drug: Polyunsaturated Fatty Acids
Title: POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 Diabetes
Acronym: POLYPHEM
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: Type 2 Diabetes;NAFLD;Obesity;Dyslipidemia;Hypertension;Metabolic Syndrome
Interventions: Dietary Supplement: diet with/without supplementation
Outcome Measures: change in insulin secretion (glucagon stimulation test);change in hepatic fat content (MR-S);change in insulin secretion in the mixed-meal tolerance test (MMTT) - combined parameter;change in insulin sensitivity in the mixed-meal tolerance test (MMTT) - combined parameter;change in blood glucose profile in the mixed-meal tolerance test (MMTT) - combined parameterinflammatory reaction in subcutaneous adipose tissue (SCAT analysis on protein and RNA level - IL-1; IL1beta, IL-6);change in parameters of peripheral neuropathy - vibration threshold;change in parameters of peripheral neuropathy - thermal sensitivity;change in parameters of peripheral neuropathy - pain thresholds;change in parameters of autonomic neuropathy - measures of cardio-autonomic neuropathy (MSDD);change in parameters of autonomic neuropathy - measures of cardio-autonomic neuropathy (SANN)
Sponsor/Collaborators: German Institute of Human Nutrition
Gender: All
Age: 18 Years79 Years
Phases: Not applicable
Enrollment: 200
Study Type: Interventional
Study Designs: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Start Date: 21/11/2016
Completion Date: --
Results First Posted: --
Last Update Posted: 12 December 2020
Locations: Germany
URL: https://clinicaltrials.gov/show/NCT03047668